- Condition: Heart Failure
Interventions: Drug: Tolvaptan or Samsca; Drug: placebo or sugar pill
Sponsors: Cardiovascular Clinical Science Foundation; Cardiovascular Clinical Science Foundation; Otsuka America Pharmaceutical
Not yet recruiting - verified April 2012 - Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin Ophthalmic Solution, 0.5%; Drug: Ofloxacin Ophthalmic Solution, 0.3%
Sponsors: Alcon Research; Alcon Research
Recruiting - verified May 2012 - Condition: Suppression of Ovulation
Interventions: Drug: 10 µg/day E2 with NES 200® µg/day; Drug: 20 µg/day E2 with NES 200® µg/day; Drug: 40 µg/day E2 with NES 200® µg/day
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2012 - Conditions: Pharmacokinetics of Isavuconazole; Healthy Volunteers
Interventions: Drug: Isavuconazole; Drug: Placebo; Drug: Moxifloxacin
Sponsors: Astellas Pharma Inc; Astellas Pharma Global Development, Inc.; Basilea Pharmaceutica International Ltd
Recruiting - verified April 2012 - Condition: Postpartum Contraception
Intervention: Drug: Levonorgestrel-releasing intrauterine system
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Society of Family Planning
Recruiting - verified March 2012 - Conditions: Prevention of Pregnancy; Postpartum Contraception
Interventions: Drug: Levonorgestrel IUS or Copper T IUD; Drug: Levonorgestrel IUS or Copper T IUD
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Society of Family Planning
Recruiting - verified May 2012 - Conditions: Vaginal Inflammation; Vaginal Infections
Interventions: Drug: Imiquimod; Drug: HEC Placebo; Drug: Nonoxynol-9
Sponsors: CONRAD; CONRAD
Recruiting - verified May 2012 - Condition: Alcoholism
Interventions: Drug: Korlym (mifepristone); Drug: Sugar Pill
Sponsors: The Scripps Research Institute; The Scripps Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified April 2012 - Condition: Coronary Heart Disease
Interventions: Drug: Ethinyl Estradiol-Levonorgestrel combination; Drug: leuprolide acetate; Drug: Estradiol; Drug: Progesterone
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Medical Research Foundation, Oregon
Recruiting - verified March 2012 - Conditions: Pregnancy Prevention; Emergency Contraception
Interventions: Drug: oral levonorgestrel; Device: levonorgestrel IUS
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified February 2012 - Condition: Healthy Volunteers
Interventions: Drug: LY2484595; Drug: Placebo; Drug: Moxifloxacin
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Healthy Volunteers
Interventions: Drug: LY3009104; Drug: Placebo; Drug: moxifloxacin
Sponsors: Eli Lilly and Company; Eli Lilly and Company; Incyte Corporation
Recruiting - verified March 2012 - Conditions: Glaucoma; Ocular Hypertension
Interventions: Drug: 0.1% brimonidine tartrate and 0.01% bimatoprost; Drug: 0.01% bimatoprost and 0.2% hypromellose
Sponsors: Allergan; Allergan
Recruiting - verified January 2012 - Condition: Pediculosis
Interventions: Drug: Ha44; Drug: Ha44 Placebo; Drug: Moxifloxacin Placebo; Drug: Moxifloxacin
Sponsors: Hatchtech Pty Ltd; Hatchtech Pty Ltd
Not yet recruiting - verified January 2012 - Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole; Drug: Dexpramipexole; Drug: Dexpramipexole Placebo; Drug: Moxifloxacin
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified January 2012 - Condition: Congenital Central Hypoventilation Syndrome
Intervention: Drug: Desogestrel
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles
Not yet recruiting - verified February 2012 - Condition: Anorexia
Interventions: Drug: megestrol acetate; Drug: Arm B (megestrol plus mirtazapine)
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified April 2012 - Condition: Bladder Cancer
Interventions: Drug: Genistein; Drug: Sugar pill
Sponsors: Emory University; Emory University
Not yet recruiting - verified March 2012 - Developing Memory Reconsolidation Blockers as Novel Post-traumatic Stress Disorder (PTSD) TreatmentsCondition: Post-traumatic Stress Disorder
Interventions: Drug: Mifepristone; Drug: Cycloserine; Drug: sugar pill
Sponsors: Massachusetts General Hospital; Roger K. Pitman, MD
Recruiting - verified December 2011 - Conditions: Male Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
Interventions: Drug: mifepristone; Drug: placebo; Drug: nab-paclitaxel
Sponsors: University of Chicago; Rita Nanda
Recruiting - verified December 2011 - Condition: Breakthrough Bleeding
Intervention: Drug: Doxycycline
Sponsors: University of Hawaii; University of Hawaii; Charles Drew University of Medicine and Science; Meharry Medical College
Recruiting - verified March 2012 - Conditions: Insulin Sensitivity; Cardiovascular Risk; Perimenopausal Disorder
Intervention: Drug: Ortho Cyclen®
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; American Heart Association
Recruiting - verified November 2011 - Conditions: Contraception; Postpartum Depression; Lactation
Interventions: Drug: Depot medroxyprogesterone acetate; Drug: Depot medroxyprogesterone acetate
Sponsors: University of Pittsburgh; University of Pittsburgh; Society of Family Planning
Not yet recruiting - verified October 2011 - Conditions: Relapsing-remitting Multiple Sclerosis; Secondary-progressive Multiple Sclerosis; Primary-progressive Multiple Sclerosis
Interventions: Drug: estriol; Other: Placebo; Drug: Norethindrone; Other: Progestin Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Adeona Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Weight Gain; Disorder of Bone Density and Structure, Unspecified
Intervention: Drug: Depot medroxyprogesterone acetate (DMPA)
Sponsors: Nationwide Children's Hospital; Nationwide Children's Hospital; Society of Family Planning
Recruiting - verified October 2011 - Condition: Cervical Preparation
Interventions: Drug: Mifepristone; Device: osmotic dilators
Sponsors: Boston University; Boston University; Society of Family Planning
Recruiting - verified October 2011 - Condition: Menorrhagia
Interventions: Drug: Oral tranexamic acid; Drug: Oral Contraceptive Pills
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Texas Children's Hospital
Recruiting - verified September 2011 - Conditions: Uterine Fibroids; Heavy Uterine Bleeding
Interventions: Drug: placebo; Drug: elagolix, elagolix sodium; Drug: Placebo; Drug: elagolix, elagolix sodium; Other: Elagolix Dose 1 plus estradiol/norethindrone acetate; Drug: Placebo Cohort 4; Drug: Elagolix, elagolix sodium; Drug: Elagolix, elagolix sodium
Sponsors: Abbott; Abbott; Neurocrine Biosciences
Recruiting - verified April 2012 - Conditions: Contraceptive Usage; Opioid Dependence
Interventions: Behavioral: Contraceptive management program; Other: Usual care
Sponsors: University of Vermont; University of Vermont
Recruiting - verified December 2011 - Condition: Hypertension
Interventions: Device: Electronic pill tray direct reporting to physician (Telephone-Linked Care: Hypertension 2- Electronic Pill Tray); Behavioral: Patient self reporting of medication adherence
Sponsors: Boston Medical Center; Boston Medical Center
Not yet recruiting - verified August 2011 - Conditions: Hyperandrogenemia; Polycystic Ovary Syndrome
Interventions: Drug: Progesterone; Drug: Estrace (estrogen)
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Metformin; Drug: Progesterone; Drug: estrace
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Flutamide; Drug: Progesterone; Drug: estrace (estradiol)
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: Glaucoma
Interventions: Drug: bimatoprost ophthalmic solution formulation A, bimatoprost vehicle; Drug: timolol ophthalmic solution
Sponsors: Allergan; Allergan
Recruiting - verified November 2011 - Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel; Drug: Depo-medroxyprogesterone acetate (DMPA); Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
Sponsors: CONRAD; CONRAD
Recruiting - verified May 2012 - Conditions: Endocrine Disease; Diabetes
Intervention: Drug: Mifepristone
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Conditions: Hot Flashes; Menopause; Vasomotor Disturbance
Interventions: Drug: Low-dose 17-ß-estradiol; Drug: Venlafaxine XR; Drug: Placebo
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Office of Research on Women's Health (ORWH)
Recruiting - verified December 2011 - Condition: Vaginosis, Bacterial
Intervention: Drug: Etonogestrel /Ethinyl Estradiol Contraceptive Vaginal Ring
Sponsors: Eastern Virginia Medical School; Eastern Virginia Medical School; Merck
Recruiting - verified April 2012 - Condition: HIV Infected
Intervention: Drug: Tenofovir, Emtricitabine, Atazanavir, Ritonavir
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Conditions: Heavy Menstrual Bleeding; Menorrhagia; Hypermenorrhea
Interventions: Drug: Norethindrone acetate pretreatment; Other: No pretreatment
Sponsors: Scott and White Hospital & Clinic; Scott and White Hospital & Clinic
Recruiting - verified January 2011 - Conditions: Estrogen Receptor-positive Breast Cancer; Progesterone Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
Interventions: Biological: therapeutic estradiol; Drug: exemestane; Other: laboratory biomarker analysis; Other: enzyme-linked immunosorbent assay
Sponsors: University of Arizona; University of Arizona; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Bipolar Affective Disorders; Cyclothymic Disorder; Schizoaffective Disorder; Major Depressive Disorder; Dysthymic Disorder; Obsessive-Compulsive Disorder; Panic Disorder; Posttraumatic Stress Disorder; Premenstrual Dysphoric Disorder; Social Anxiety Disorder
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified June 2011 - Condition: Polycystic Ovary Syndrome
Intervention: Drug: folate-boosted 3 mg DRSP/20 μg EE-24/4 oral contraceptive
Sponsors: BC Women's Hospital & Health Centre; BC Women's Hospital & Health Centre; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Recruiting - verified March 2012 - Condition: Medical Abortion, Complete or Unspecified, Without Complication
Interventions: Drug: DMPA; Drug: Etonogestrel implant
Sponsors: Boston University; Boston University; Anonymous
Recruiting - verified September 2011 - Condition: Contraception
Interventions: Drug: Conceptrol; Drug: Amphora
Sponsors: Evofem Inc.; Evofem Inc.; Health Decisions
Recruiting - verified May 2012 - Condition: Birth Control
Intervention:
Sponsors: Maricopa Integrated Health System; Maricopa Integrated Health System; Fertility Centers of Arizona; St. Joseph's Hospital and Medical Center, Phoenix
Not yet recruiting - verified January 2012 - Conditions: Perimenopause; Menopause; Depression
Intervention: Drug: Estradiol
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Anorexia Nervosa
Interventions: Drug: RhIGF-1 with transdermal 17-beta estradiol; Drug: Placebo and transdermal 17-beta estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; The Hospital for Sick Children
Recruiting - verified February 2012 - Condition: Contraception
Intervention: Drug: one of 5 products
Sponsors: FHI 360; FHI 360; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: HIV-1 Infection
Intervention: Drug: depo-medroxyprogesterone acetate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: Cataracts
Interventions: Drug: Moxifloxacin; Drug: besifloxacin
Sponsors: Bucci Laser Vision Institute; Bucci Laser Vision Institute
Recruiting - verified July 2011 - Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: AT-101; Drug: Docetaxel
Sponsors: University of Michigan Cancer Center; University of Michigan Cancer Center
Recruiting - verified October 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Estradiol, medroxyprogesterone, hydrocortisone, growth hormone; Drug: Matching placebo
Sponsors: Sansum Diabetes Research Institute; Sansum Diabetes Research Institute
Not yet recruiting - verified July 2011 - Condition: Borderline Personality Disorder
Interventions: Drug: mifepristone; Drug: Placebo
Sponsors: Indiana University; Indiana University
Recruiting - verified March 2012 - Condition: Menopause
Interventions: Drug: estradiol transdermal system; Drug: Amino acid; Drug: Placebo Patch; Drug: Placebo
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Chronic Oral Food Refusal
Interventions: Drug: Amitriptyline 1 mg/kg; Drug: Placebo
Sponsors: University of Kansas; Ann Davis, PhD, MPH, ABPP
Recruiting - verified March 2012 - Condition: Contraception
Intervention: Behavioral: Treatment group: receives counseling phone call intervention
Sponsors: University of California, San Francisco; University of California, San Francisco; Society of Family Planning
Recruiting - verified April 2012 - Condition: Contraception
Interventions: Drug: Lidocaine; Drug: Lubricant
Sponsors: University of Tennessee; University of Tennessee
Recruiting - verified June 2011 - Condition: Contraception
Interventions: Drug: levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2; Drug: levonorgestrel patch with BMI <32 kg/m2; Drug: levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2; Drug: levonorgestrel patch with BMI <32 kg/m2
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Health Decisions
Recruiting - verified February 2012 - Conditions: Keratoconus; Ectasia; Degeneration
Interventions: Drug: Ciprofloxicine or Vigamox or other.; Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc); Drug: Steroid (FML, Pred Forte, Flarex, etc.)
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified April 2012 - Condition: Menorrhagia
Interventions: Drug: Estradiol 30 mcg / Levonorgestrel 150 mcg monophasic oral contraceptive pills; Drug: Naproxen sodium pills; Device: Nova Sure Radiofrequency Endometrial Ablation
Sponsors: Mayo Clinic; Mayo Clinic; Hologic, Inc.
Recruiting - verified January 2012 - Condition: Open-Angle Glaucoma
Interventions: Drug: bimatoprost ophthalmic formulation A, bimatoprost ophthalmic solution 0.03%; Drug: bimatoprost ophthalmic formulation B, bimatoprost ophthalmic solution 0.03%; Drug: bimatoprost ophthalmic formulation C, bimatoprost ophthalmic solution 0.03%
Sponsors: Allergan; Allergan
Recruiting - verified December 2011 - Condition: Orthostatic Intolerance
Interventions: Drug: 17 beta estradiol, progesterone, ganirelix acetate; Drug: 17 beta estradiol, progesterone, ganirelix acetate
Sponsors: Yale University; Yale University
Recruiting - verified August 2011 - Condition: To Determine the PK Profile of MPA When Injected Aubcutaneously Into the Upper Arm
Intervention: Drug: Medroxyprogesterone acetate
Sponsors: FHI 360; FHI 360; Eastern Virginia Medical School
Recruiting - verified October 2011 - Condition: Vitamin B6 Deficiency
Intervention: Dietary Supplement: Vitamin B6
Sponsors: University of Florida; University of Florida
Recruiting - verified March 2012 - Condition: Cocaine Dependence
Interventions: Drug: Mifepristone; Drug: placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified December 2011 - Conditions: Schizophrenia; Smoking Cessation
Interventions: Other: Sugar Pill; Drug: Varenicline; Drug: Bupropion HCl
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Contraception
Interventions: Drug: ellaOne® (ulipristal acetate); Drug: ellaOne® (ulipristal acetate)
Sponsors: HRA Pharma; HRA Pharma
Recruiting - verified March 2012 - Condition: Obstructive Sleep Apnea
Interventions: Drug: budesonide nasal spray and a montelukast pill; Drug: Placebo: sugar pill and salt water nasal spray
Sponsors: Romaker & Associates; Romaker & Associates; Merck; AstraZeneca
Recruiting - verified July 2011 - Condition: Female Breast Cancer
Intervention: Drug: Estradiol
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Condition: Intra-Abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Condition: Infections
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
Sponsors: Bayer; Bayer
Recruiting - verified May 2012 - Conditions: Eyelash Hypotrichosis; Alopecia Areata
Interventions: Drug: bimatoprost ophthalmic solution 0.03%; Drug: Vehicle Sterile Solution
Sponsors: Allergan; Allergan
Recruiting - verified November 2011 - Conditions: Keratoconus; Ectasia; Degeneration
Interventions: Drug: Ciprofloxicine or Vigamox or other.; Drug: Nonsteroidal (Acular, Voltaren Xibrom, etc); Drug: Steroid (FML, Pred Forte, Flarex, etc.)
Sponsors: Innovative Medical; Innovative Medical
Recruiting - verified February 2012 - Conditions: Alopecia; Breast Cancer
Interventions: Drug: bimatoprost ophthalmic solution; Drug: placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Condition: Contraception
Interventions: Drug: LNG20; Drug: Mirena
Sponsors: Medicines360; Medicines360
Recruiting - verified May 2012 - Condition: Medical Abortion
Intervention: Drug: Mifepristone and misoprostol
Sponsors: Gynuity Health Projects; Gynuity Health Projects
Recruiting - verified November 2011 - Conditions: Atrophic Vaginitis; Breast Cancer
Intervention: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified April 2012 - Condition: Exercise-related Amenorrhea
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone; Drug: Ethinyl Estradiol + Desogestrel; Dietary Supplement: Elemental Calcium and Vitamin D
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: buserelin; Drug: flutamide; Drug: goserelin acetate; Drug: leuprolide acetate; Drug: triptorelin; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Pregnancy; Effective Contraceptive Use; Family Planning
Intervention: Other: Enhanced NFP Care
Sponsors: Oregon Health and Science University; Oregon Health and Science University; University of Colorado, Denver; Public Health - Clark County; Pulbic Health - Thurston County; Public Health - Seattle and King County
Recruiting - verified August 2011 - Condition: Premenstrual Dysphoric Disorder
Interventions: Drug: low dose oral contraceptive (20 ug ethinyl estradiol + 3 mg drospirenone); Drug: 20 ug ethinyl estradiol + 3 mg drospirenone; Drug: placebo
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Recruiting - verified May 2012 - Condition: Posttraumatic Stress Disorder
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: James J. Peters Veterans Affairs Medical Center; James J. Peters Veterans Affairs Medical Center
Recruiting - verified September 2011 - Conditions: Hyperplasia; Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Bayer
Recruiting - verified November 2011 - Condition: Contraception
Interventions: Drug: ortho tricyclen; Drug: Trinessa
Sponsors: William Beaumont Hospitals; William Beaumont Hospitals
Recruiting - verified August 2011 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Orlistat (Alli) and Lifestyle Intervention with exercise and diet; Drug: Loestrin 1/20; Drug: Orlistat (Alli) and Loestrin 1/20
Sponsors: Penn State University; Penn State University; University of Pennsylvania
Recruiting - verified November 2011 - Condition: Chronic Multisymptom Illness in Gulf War Veterans
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: Bronx Veterans Medical Research Foundation, Inc; Bronx Veterans Medical Research Foundation, Inc; U.S. Army Medical Research and Materiel Command
Recruiting - verified September 2011 - Conditions: Psychotic Depression; Major Depression With Psychotic Features; Psychosis
Interventions: Drug: mifepristone; Drug: placebo
Sponsors: Corcept Therapeutics; Corcept Therapeutics
Recruiting - verified February 2012 - Condition: Conjunctivitis
Interventions: Drug: moxifloxacin; Drug: polytrim
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011 - Condition: Cocaine Addictions
Interventions: Drug: sugar pill; Drug: carvedilol; Drug: Methadone
Sponsors: Yale University; Yale University; National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2011 - Conditions: Aplastic Anemia; Menorrhagia; Amenorrhea
Intervention: Drug: Lo-Ovral Oral Contraceptive Pills
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Conditions: Atypical Endometrial Hyperplasia; Endometrial Carcinoma
Intervention: Drug: Megestrol Acetate
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified March 2012 - Condition: Endometriosis
Interventions: Drug: Conjugated equine estrogens; Drug: Placebo; Drug: Norethindrone acetate
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified June 2011 - Conditions: Polycystic Ovary Syndrome; Metabolic Syndrome
Interventions: Drug: Metformin; Drug: flutamide; Drug: drospirenone; Other: placebo
Sponsors: Northwestern University; Northwestern University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2012 - Condition: Menopause
Interventions: Drug: Prempro, premarin, provera conjugated estrogens, medroxyprogesterone acetate; Drug: Estradiol , estriol , progesterone; Drug: estradiol,progesterone; Drug: estriol, progesterone
Sponsors: University of Kansas; Jeanne Drisko, MD, CNS, FACN; Private Foundation through KU Endowment; University of Kansas
Recruiting - verified September 2011 - Condition: Systemic Lupus Erythematosus
Intervention: Drug: Triptorelin pamoate
Sponsors: FDA Office of Orphan Products Development; FDA Office of Orphan Products Development; Watson Pharmaceuticals
Recruiting - verified August 2011 - Conditions: Postpartum Depression; Depression
Intervention: Drug: 17 beta-estradiol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011
 |
Contraceptives Clinical Trials |
